全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

Immunohistochemical Expression of Ki-67, PCNA, pRb, p16, p53, Bcl-2 and Bax in Esophageal Adenocarcinoma and Barrett’s Associated Dysplasia

Estudio comparativo de la expresión de p53, Ki67, bcl-2 y CK20 en el carcinoma transicional superficial de vejiga: correlación con la recurrencia, grado histológico y estadio clínico

Expressions of bax, bcl-2 and Ki-67 in Odontogenic Keratocysts (Keratocystic Odontogenic Tumor) in Comparison with Ameloblastomas and Radicular Cysts

P53, MAPK, topoisomerase II alpha and Ki67 immunohistochemical expression and KRAS/BRAF mutation in ovarian serous carcinomas

A simple immunohistochemical panel comprising 2 conventional markers, Ki67 and p53, is a powerful tool for predicting patient outcome in luminal-type breast cancer

Telomerase Activity and MDS/EVI Gene Fusion in Myelodysplastic Syndrome. Correlation to the Immunohistochemical Expression of Ki-67, Bcl-2 and p53 in Bone Marrow Biopsy Samples

Poor outcome in patients with diffuse large B-cell lymphoma is associated with high percentage of bcl-2 and Ki 67-positive tumor cells

Effect of Dietary and Topical Celecoxib on Expression of bcl-2, bax, c-erb-B2 and Ki67 in Carcinogen-Induced Tongue Carcinoma in Rat

Immunohistochemical Expression of ki-67 and p53 in Colorectal Adenomas: A Clinicopathological Study

Immunohistochemical evaluation of p53 and Ki-67 proteins in colorectal adenomas

更多...

Analysis of the immunohistochemical expressions of p53, bcl-2 and Ki-67 in colorectal adenocarcinoma and their correlations with the prognostic factors

DOI: 10.1590/S0004-28032010000200005

Keywords: colorectal neoplasms, adenocarcinoma, immunohistochemistry, tumor suppressor protein p53, proto-oncogene proteins c-bcl-2, bcl-2 homologous antagonist-killer protein.

Full-Text   Cite this paper   Add to My Lib

Abstract:

context: search of tumors markers that allow treatment with higher survival rates, and indicate the response to treatment and recurrence of cancer objective: to analyze the immunoexpression of the proteins p53, bcl-2 and ki-67 in colorectal adenocarcinoma and correlate them with the clinical-pathological prognostic factors. method: tissue microarray paraffin blocks were made from colorectal adenocarcinoma tissue resected from 82 patients who had undergone surgery but not chemotherapy or radiotherapy, at "hospital s?o paulo", s?o paulo, sp, brazil, between 2002 and 2005. thin sections (4 μm) were subjected to immunohistochemical reactions, and immunoexpression staining scores were obtained. the scores were correlated with the degree of cell differentiation, staging, disease-free interval, recurrence, survival and specific mortality. the study variables were analyzed using the chi-square and kaplan-meier tests to investigate associations with the markers. the significance of the differences between the curves of the disease-free interval and survival was analyzed using the logrank and wilcoxon tests. results: the immunohistochemical expression of p53 was positive in 70 tumors (85.4%) and negative in 12 (14.6%). the expression of bcl-2 was positive in 26 (31.7%) and negative in 56 (68.3%). the expression of ki-67 was positive in 62 (75.6%) and negative in 20 (24.4%). there was no statistically significant correlation between the expressions of these markers separately or in conjunction, in relation to the degree of cell differentiation, staging, disease-free interval, survival and specific mortality. in relation to recurrence, there was a statistically significant correlation with positive expression of ki-67 (p = 0.035). conclusion: the immunohistochemical expression of ki-67 in colorectal cancer is associated with recurrence of this disease.

Full-Text

comments powered by Disqus